{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:37:02Z","timestamp":1785868622657,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SAS-Tubitak","award":["JRP 2015\/7"],"award-info":[{"award-number":["JRP 2015\/7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11064-019-02736-1","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T21:06:16Z","timestamp":1548709576000},"page":"1056-1064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["3-Mercapto-5H-1,2,4-Triazino[5,6-b]Indole-5-Acetic Acid (Cemtirestat) Alleviates Symptoms of Peripheral Diabetic Neuropathy in Zucker Diabetic Fatty (ZDF) Rats: A Role of Aldose Reductase"],"prefix":"10.1007","volume":"44","author":[{"given":"Marta","family":"Soltesova Prnova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Svik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bezek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Kovacikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cimen","family":"Karasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Stefek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"2736_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2013.12.005","volume":"80","author":"R Singh","year":"2014","unstructured":"Singh R, Kishore L, Kaur N (2014) Diabetic peripheral neuropathy: current perspective and future. Directions Pharmacol Res 80:21\u201335. https:\/\/doi.org\/10.1016\/j.phrs.2013.12.005","journal-title":"Directions Pharmacol Res"},{"key":"2736_CR2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7898.1","author":"K Juster-Switlyk","year":"2016","unstructured":"Juster-Switlyk K, Smith AG (2016) Updates in diabetic peripheral neuropathy. F1000Res 5 (F1000 Faculty Rev). https:\/\/doi.org\/10.12688\/f1000research.7898.1","journal-title":"F1000Res 5 (F1000 Faculty Rev)"},{"issue":"5","key":"2736_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/dmrr.2397","volume":"29","author":"AJ Boulton","year":"2013","unstructured":"Boulton AJ, Kempler P, Ametov A, Ziegler D (2013) Whither pathogenetic treatments for diabetic polyneuropathy? Diabetes Metab Res Rev 29(5):327\u2013333. https:\/\/doi.org\/10.1002\/dmrr.2397","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"2736_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.7326\/M14-0511","volume":"161","author":"ML Griebeler","year":"2014","unstructured":"Griebeler ML, Morey-Vargas OL, Brito JP, Tsapas A, Wang Z, Carranza Leon BG, Phung OJ, Montori VM, Murad MH (2014) Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med 161(9):639\u2013649. https:\/\/doi.org\/10.7326\/M14-0511","journal-title":"Ann Intern Med"},{"issue":"20","key":"2736_CR5","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1212\/WNL.0000000000003882","volume":"88","author":"JM Waldfogel","year":"2017","unstructured":"Waldfogel JM, Nesbit SA, Dy SM, Sharma R, Zhang A, Wilson LM, Bennett WL, Yeh HC, Chelladurai Y, Feldman D, Robinson KA (2017) Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: A systematic review. Neurology 88(20):1958\u20131967. https:\/\/doi.org\/10.1212\/WNL.0000000000003882","journal-title":"Neurology"},{"issue":"2","key":"2736_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1529-8027.2008.00167.x","volume":"13","author":"DR Tomlinson","year":"2008","unstructured":"Tomlinson DR, Gardiner NJ (2008) Diabetic neuropathies: components of etiology. J Peripher Nerv Syst 13(2):112\u2013121. https:\/\/doi.org\/10.1111\/j.1529-8027.2008.00167.x","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"2736_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.nurt.2009.07.004","volume":"6","author":"IG Obrosova","year":"2009","unstructured":"Obrosova IG (2009) Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6(4):638\u2013647. https:\/\/doi.org\/10.1016\/j.nurt.2009.07.004","journal-title":"Neurotherapeutics"},{"issue":"10","key":"2736_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","volume":"7","author":"AM Vincent","year":"2011","unstructured":"Vincent AM, Callaghan BC, Smith AL, Feldman EL (2011) Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 7(10):573\u2013583. https:\/\/doi.org\/10.1038\/nrneurol.2011.137","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"2736_CR9","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman EL, Nave KA, Jensen TS, Bennett DLH (2017) New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron 93(6):1296\u20131313. https:\/\/doi.org\/10.1016\/j.neuron.2017.02.005","journal-title":"Neuron"},{"issue":"1","key":"2736_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrn2294","volume":"9","author":"DR Tomlinson","year":"2008","unstructured":"Tomlinson DR, Gardiner NJ (2008) Glucose neurotoxicity. Nat Rev Neurosci 9(1):36\u201345","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2736_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/138945008783431781","volume":"9","author":"PJ Oates","year":"2008","unstructured":"Oates PJ (2008) Aldose reductase, still a compelling target for diabetic neuropathy. Curr Drug Targets 9(1):14\u201336","journal-title":"Curr Drug Targets"},{"key":"2736_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2174\/092986709787458362","volume":"16","author":"P Alexiou","year":"2009","unstructured":"Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos VJ (2009) Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr Med Chem 16:734\u2013752","journal-title":"Curr Med Chem"},{"key":"2736_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1515\/bmc.2011.002","volume":"2","author":"K Ramana","year":"2011","unstructured":"Ramana K (2011) Aldose reductase: new insights for an old enzyme. Biomol Concepts 2:103\u2013114. https:\/\/doi.org\/10.1515\/BMC.2011.002","journal-title":"Biomol Concepts"},{"key":"2736_CR14","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1021\/jm500907a","volume":"58","author":"R Maccari","year":"2015","unstructured":"Maccari R, Ottan\u00e0 R (2015) Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions. J Med Chem 58:2047\u20132067. https:\/\/doi.org\/10.1021\/jm500907a","journal-title":"J Med Chem"},{"issue":"2","key":"2736_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/1389557515666150909143737","volume":"16","author":"AS Grewal","year":"2016","unstructured":"Grewal AS, Bhardwaj S, Pandita D, Lather V, Sekhon BS (2016) Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases. Mini Rev Med Chem 16(2):120\u2013162","journal-title":"Mini Rev Med Chem"},{"key":"2736_CR16","doi-asserted-by":"publisher","first-page":"CD004572","DOI":"10.1002\/14651858.CD004572.pub2","volume":"4","author":"C Chalk","year":"2007","unstructured":"Chalk C, Benstead TJ, Moore F (2007) Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database Syst Rev 4:CD004572. https:\/\/doi.org\/10.1002\/14651858.CD004572.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2736_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jdiacomp.2009.07.005","volume":"24","author":"KE Schemmel","year":"2010","unstructured":"Schemmel KE, Padiyara RS, D\u2019Souza JJ (2010) Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications 24(5):354\u2013360. https:\/\/doi.org\/10.1016\/j.jdiacomp.2009.07.005","journal-title":"J Diabetes Complications"},{"issue":"5","key":"2736_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1592\/phco.28.5.646","volume":"28","author":"MA Ramirez","year":"2008","unstructured":"Ramirez MA, Borja NL (2008) Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy 28(5):646\u2013655. https:\/\/doi.org\/10.1592\/phco.28.5.646","journal-title":"Pharmacotherapy"},{"issue":"6","key":"2736_CR19","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1021\/jm5015814","volume":"58","author":"M Stefek","year":"2015","unstructured":"Stefek M, Soltesova Prnova M, Majekova M, Rechlin C, Heine A, Klebe G (2015) Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold. J Med Chem 58(6):2649\u20132657. https:\/\/doi.org\/10.1021\/jm5015814","journal-title":"J Med Chem"},{"key":"2736_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2018.1465851","author":"JY Zhan","year":"2018","unstructured":"Zhan JY, Ma K, Zheng QC, Yang GH, Zhang HX (2018) Exploring the interactional details between aldose reductase (AKR1B1) and 3-Mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid through molecular dynamics simulations. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2018.1465851","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"2736_CR21","first-page":"41","volume":"4","author":"M Stefek","year":"2016","unstructured":"Stefek M, Soltesova Prnova M, Ballekova J, Majekova M (2016) Cemtirestat, a novel aldose reductase inhibitor and antioxidant, in multitarget pharmacology of diabetic complications. IRAJ 4(3):41\u201344. ISSN 2321\u20139009","journal-title":"IRAJ"},{"issue":"6","key":"2736_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1179\/1351000215Y.0000000019","volume":"20","author":"MS Prnova","year":"2015","unstructured":"Prnova MS, Ballekova J, Majekova M, Stefek M (2015) Antioxidant action of 3-mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid, an efficient aldose reductase inhibitor, in a 1,1\u2032-diphenyl-2-picrylhydrazyl assay and in the cellular system of isolated erythrocytes exposed to tert-butyl hydroperoxide. Redox Rep 20(6):282\u2013288. https:\/\/doi.org\/10.1179\/1351000215Y.0000000019","journal-title":"Redox Rep"},{"key":"2736_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","volume":"52","author":"JA Buege","year":"1978","unstructured":"Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol. 52:302\u201310","journal-title":"Methods Enzymol"},{"issue":"12","key":"2736_CR24","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1021\/jm034065z","volume":"46","author":"BL Mylari","year":"2003","unstructured":"Mylari BL, Armento SJ, Beebe DA, Conn EL, Coutcher JB, Dina MS, O\u2019Gorman MT, Linhares MC, Martin WH, Oates PJ, Tess DA, Withbroe GJ, Zembrowski WJ (2003) A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3-one. J Med Chem 46(12):2283\u20132286","journal-title":"J Med Chem"},{"issue":"8","key":"2736_CR25","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.2337\/db11-1524","volume":"61","author":"H Shevalye","year":"2012","unstructured":"Shevalye H, Watcho P, Stavniichuk R, Dyukova E, Lupachyk S, Obrosova IG (2012) Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats. Diabetes 61(8):2126\u20132133. https:\/\/doi.org\/10.2337\/db11-1524","journal-title":"Diabetes"},{"issue":"2","key":"2736_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.pbb.2012.05.008","volume":"102","author":"G Vera","year":"2012","unstructured":"Vera G, L\u00f3pez-Miranda V, Herrad\u00f3n E, Mart\u00edn MI, Abalo R (2012) Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes. Pharmacol Biochem Behav 102(2):335\u2013343. https:\/\/doi.org\/10.1016\/j.pbb.2012.05.008","journal-title":"Pharmacol Biochem Behav"},{"key":"2736_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4236\/jdm.2014.41011","volume":"4","author":"S Lupachyk","year":"2014","unstructured":"Lupachyk S, Shevalye H, Watcho P, Obrosov A, Obrosova IG, Yorek MA (2014) Treatment of peripheral diabetic neuropathy in Zucker diabetic fatty (ZDF) rats with cariporide. J Diabetes Mellitus 4:59\u201366. https:\/\/doi.org\/10.4236\/jdm.2014.41011","journal-title":"J Diabetes Mellitus"},{"issue":"6","key":"2736_CR28","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2337\/db07-1737","volume":"57","author":"V Brussee","year":"2008","unstructured":"Brussee V, Guo G, Dong Y, Cheng C, Martinez JA, Smith D, Glazner GW, Fernyhough P, Zochodne DW (2008) Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model. Diabetes 57(6):1664\u20131673. https:\/\/doi.org\/10.2337\/db07-1737","journal-title":"Diabetes"},{"issue":"3","key":"2736_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jpain.2015.11.006","volume":"17","author":"RB Griggs","year":"2016","unstructured":"Griggs RB, Donahue RR, Adkins BG, Anderson KL, Thibault O, Taylor BK (2016) Pioglitazone inhibits the development of hyperalgesia and sensitization of spinal nociresponsive neurons in type 2 diabetes. J Pain 17(3):359\u2013373. https:\/\/doi.org\/10.1016\/j.jpain.2015.11.006","journal-title":"J Pain"},{"key":"2736_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.brainresbull.2016.06.013","volume":"125","author":"Y Yang","year":"2016","unstructured":"Yang Y, Zhang Z, Guan J, Liu J, Ma P, Gu K, Zhao J, Yang G, Song T (2016) Administrations of thalidomide into the rostral ventromedial medulla alleviates painful diabetic neuropathy in Zucker diabetic fatty rats. Brain Res Bull 125:144\u2013151. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.06.013","journal-title":"Brain Res Bull"},{"key":"2736_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1235","author":"E Garcia-Perez","year":"2018","unstructured":"Garcia-Perez E, Sch\u00f6nberger T, Sumalla M, Stierstorfer B, Sol\u00e0 R, Doods H, Serra J, Gorodetskaya N (2018) Behavioural, morphological and electrophysiological assessment of the effects of type 2 diabetes mellitus on large and small nerve fibres in Zucker diabetic fatty, Zucker lean and Wistar rats. Eur J Pain. https:\/\/doi.org\/10.1002\/ejp.1235","journal-title":"Eur J Pain"},{"issue":"4","key":"2736_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s00125-004-1354-2","volume":"47","author":"NA Calcutt","year":"2004","unstructured":"Calcutt NA, Freshwater JD, Mizisin AP (2004) Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47(4):718\u2013724. https:\/\/doi.org\/10.1007\/s00125-004-1354-2","journal-title":"Diabetologia"},{"key":"2736_CR33","unstructured":"Stefek M, Milackova I, D\u00edez-Dacal B, P\u00e9rez-Sala D, Soltesova Prnova M (2017) Use of 5-carboxymethyl-3-mercapto-1,2,4-triazino-[5,6-b]indoles and their pharmaceutical composition. Slovak Patent No 288508"},{"issue":"4","key":"2736_CR34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.33549\/physiolres.933034","volume":"64","author":"M Soltesova Prnova","year":"2015","unstructured":"Soltesova Prnova M, Ballekova J, Gajdosikova A, Gajdosik A, Stefek M (2015) A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats. Physiol Res 64(4):587\u2013591","journal-title":"Physiol Res"},{"issue":"11","key":"2736_CR35","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1053\/meta.2000.17723","volume":"49","author":"Y Shimoshige","year":"2000","unstructured":"Shimoshige Y, Ikuma K, Yamamoto T, Takakura S, Kawamura I, Seki J, Mutoh S, Goto T (2000) The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats. Metabolism 49(11):1395\u20131399","journal-title":"Metabolism"},{"issue":"3","key":"2736_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1463-1326.2008.00924.x","volume":"11","author":"CL Oltman","year":"2009","unstructured":"Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Yorek MA (2009) Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction. Diabetes Obes Metab 11(3):223\u2013233. https:\/\/doi.org\/10.1111\/j.1463-1326.2008.00924.x","journal-title":"Diabetes Obes Metab"},{"key":"2736_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/592760","volume":"592760","author":"L Ferreira","year":"2010","unstructured":"Ferreira L, Teixeira-de-Lemos E, Pinto F, Parada B, Mega C, Vala H, Pinto R, Garrido P, Sereno J, Fernandes R, Santos P, Velada I, Melo A, Nunes S, Teixeira F, Reis F (2010) Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm 2010:592760:1\u201311. https:\/\/doi.org\/10.1155\/2010\/592760","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2736_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.orcp.2014.10.001","volume":"9","author":"I Wakabayashi","year":"2015","unstructured":"Wakabayashi I, Shimomura T, Nakanishi M, Uchida K (2015 Jan-Feb) Elevation of circulating LOX-1 ligand levels in Zucker obese and diabetic rats. Obes Res Clin Pract 9(1):26\u201330. https:\/\/doi.org\/10.1016\/j.orcp.2014.10.001","journal-title":"Obes Res Clin Pract"},{"key":"2736_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cbi.2011.02.023","volume":"191","author":"SK Srivastava","year":"2011","unstructured":"Srivastava SK, Yadav UC, Reddy AB, Saxena A, Tammali R, Shoeb M, Ansari NH, Bhatnagar A, Petrash MJ, Srivastava S, Ramana KV (2011) Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. Chem Biol Interaction 191:330\u2013338","journal-title":"Chem Biol Interaction"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-019-02736-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T23:45:57Z","timestamp":1606261557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-019-02736-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2736"],"URL":"https:\/\/doi.org\/10.1007\/s11064-019-02736-1","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}